Release 5 Draft Ballot

This is the Continuous Integration Build of FHIR (will be incorrect/inconsistent at times).
See the Directory of published versions

4.4.1.241 Value Set http://hl7.org/fhir/ValueSet/vaccine-code

Public Health and Emergency Response Work Group Maturity Level: 1Draft Use Context: Any

This is a value set defined by the FHIR project.

Summary

Defining URL:http://hl7.org/fhir/ValueSet/vaccine-code
Version:4.6.0
Name:VaccineAdministeredValueSet
Title:Vaccine Administered Value Set
Definition:

This identifies the vaccine substance administered - CVX codes.

Committee:Public Health and Emergency Response Work Group
OID:2.16.840.1.113883.3.88.12.80.22 (for OID based terminology systems)
Source ResourceXML / JSON

This value set is used in the following places:


This value set includes codes based on the following rules:

 

This expansion generated 06 Dec 2021


This value set contains 287 concepts

Expansion based on http://hl7.org/fhir/sid/cvx version 20210406

CodeSystemDisplayDefinition
54http://hl7.org/fhir/sid/cvxadenovirus vaccine, type 4, live, oral
55http://hl7.org/fhir/sid/cvxadenovirus vaccine, type 7, live, oral
82http://hl7.org/fhir/sid/cvxadenovirus vaccine, unspecified formulation
24http://hl7.org/fhir/sid/cvxanthrax vaccine
19http://hl7.org/fhir/sid/cvxBacillus Calmette-Guerin vaccine
27http://hl7.org/fhir/sid/cvxbotulinum antitoxin
26http://hl7.org/fhir/sid/cvxcholera vaccine, unspecified formulation
29http://hl7.org/fhir/sid/cvxcytomegalovirus immune globulin, intravenous
56http://hl7.org/fhir/sid/cvxdengue fever vaccine
12http://hl7.org/fhir/sid/cvxdiphtheria antitoxin
28http://hl7.org/fhir/sid/cvxdiphtheria and tetanus toxoids, adsorbed for pediatric use
20http://hl7.org/fhir/sid/cvxdiphtheria, tetanus toxoids and acellular pertussis vaccine
106http://hl7.org/fhir/sid/cvxdiphtheria, tetanus toxoids and acellular pertussis vaccine, 5 pertussis antigens
107http://hl7.org/fhir/sid/cvxdiphtheria, tetanus toxoids and acellular pertussis vaccine, unspecified formulation
110http://hl7.org/fhir/sid/cvxDTaP-hepatitis B and poliovirus vaccine
50http://hl7.org/fhir/sid/cvxDTaP-Haemophilus influenzae type b conjugate vaccine
120http://hl7.org/fhir/sid/cvxdiphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV)
130http://hl7.org/fhir/sid/cvxDiphtheria, tetanus toxoids and acellular pertussis vaccine, and poliovirus vaccine, inactivated
01http://hl7.org/fhir/sid/cvxdiphtheria, tetanus toxoids and pertussis vaccine
22http://hl7.org/fhir/sid/cvxDTP-Haemophilus influenzae type b conjugate vaccine
102http://hl7.org/fhir/sid/cvxDTP- Haemophilus influenzae type b conjugate and hepatitis b vaccine
57http://hl7.org/fhir/sid/cvxhantavirus vaccine
52http://hl7.org/fhir/sid/cvxhepatitis A vaccine, adult dosage
83http://hl7.org/fhir/sid/cvxhepatitis A vaccine, pediatric/adolescent dosage, 2 dose schedule
84http://hl7.org/fhir/sid/cvxhepatitis A vaccine, pediatric/adolescent dosage, 3 dose schedule
31http://hl7.org/fhir/sid/cvxhepatitis A vaccine, pediatric dosage, unspecified formulation
85http://hl7.org/fhir/sid/cvxhepatitis A vaccine, unspecified formulation
104http://hl7.org/fhir/sid/cvxhepatitis A and hepatitis B vaccine
30http://hl7.org/fhir/sid/cvxhepatitis B immune globulin
08http://hl7.org/fhir/sid/cvxhepatitis B vaccine, pediatric or pediatric/adolescent dosage
42http://hl7.org/fhir/sid/cvxhepatitis B vaccine, adolescent/high risk infant dosage
43http://hl7.org/fhir/sid/cvxhepatitis B vaccine, adult dosage
44http://hl7.org/fhir/sid/cvxhepatitis B vaccine, dialysis patient dosage
45http://hl7.org/fhir/sid/cvxhepatitis B vaccine, unspecified formulation
58http://hl7.org/fhir/sid/cvxhepatitis C vaccine
59http://hl7.org/fhir/sid/cvxhepatitis E vaccine
60http://hl7.org/fhir/sid/cvxherpes simplex virus, type 2 vaccine
46http://hl7.org/fhir/sid/cvxHaemophilus influenzae type b vaccine, PRP-D conjugate
47http://hl7.org/fhir/sid/cvxHaemophilus influenzae type b vaccine, HbOC conjugate
48http://hl7.org/fhir/sid/cvxHaemophilus influenzae type b vaccine, PRP-T conjugate
49http://hl7.org/fhir/sid/cvxHaemophilus influenzae type b vaccine, PRP-OMP conjugate
17http://hl7.org/fhir/sid/cvxHaemophilus influenzae type b vaccine, conjugate unspecified formulation
51http://hl7.org/fhir/sid/cvxHaemophilus influenzae type b conjugate and Hepatitis B vaccine
61http://hl7.org/fhir/sid/cvxhuman immunodeficiency virus vaccine
118http://hl7.org/fhir/sid/cvxhuman papilloma virus vaccine, bivalent
62http://hl7.org/fhir/sid/cvxhuman papilloma virus vaccine, quadrivalent
86http://hl7.org/fhir/sid/cvximmune globulin, intramuscular
87http://hl7.org/fhir/sid/cvximmune globulin, intravenous
14http://hl7.org/fhir/sid/cvximmune globulin, unspecified formulation
111http://hl7.org/fhir/sid/cvxinfluenza virus vaccine, live, attenuated, for intranasal use
15http://hl7.org/fhir/sid/cvxinfluenza virus vaccine, split virus (incl. purified surface antigen)-retired CODE
16http://hl7.org/fhir/sid/cvxinfluenza virus vaccine, whole virus
88http://hl7.org/fhir/sid/cvxinfluenza virus vaccine, unspecified formulation
123http://hl7.org/fhir/sid/cvxinfluenza virus vaccine, H5N1, A/Vietnam/1203/2004 (national stockpile)
10http://hl7.org/fhir/sid/cvxpoliovirus vaccine, inactivated
02http://hl7.org/fhir/sid/cvxtrivalent poliovirus vaccine, live, oral
89http://hl7.org/fhir/sid/cvxpoliovirus vaccine, unspecified formulation
39http://hl7.org/fhir/sid/cvxJapanese Encephalitis Vaccine SC
63http://hl7.org/fhir/sid/cvxJunin virus vaccine
64http://hl7.org/fhir/sid/cvxleishmaniasis vaccine
65http://hl7.org/fhir/sid/cvxleprosy vaccine
66http://hl7.org/fhir/sid/cvxLyme disease vaccine
03http://hl7.org/fhir/sid/cvxmeasles, mumps and rubella virus vaccine
04http://hl7.org/fhir/sid/cvxmeasles and rubella virus vaccine
94http://hl7.org/fhir/sid/cvxmeasles, mumps, rubella, and varicella virus vaccine
67http://hl7.org/fhir/sid/cvxmalaria vaccine
05http://hl7.org/fhir/sid/cvxmeasles virus vaccine
68http://hl7.org/fhir/sid/cvxmelanoma vaccine
32http://hl7.org/fhir/sid/cvxmeningococcal polysaccharide vaccine (MPSV4)
103http://hl7.org/fhir/sid/cvxmeningococcal C conjugate vaccine
114http://hl7.org/fhir/sid/cvxmeningococcal polysaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4P)
108http://hl7.org/fhir/sid/cvxmeningococcal ACWY vaccine, unspecified formulation
07http://hl7.org/fhir/sid/cvxmumps virus vaccine
69http://hl7.org/fhir/sid/cvxparainfluenza-3 virus vaccine
11http://hl7.org/fhir/sid/cvxpertussis vaccine
23http://hl7.org/fhir/sid/cvxplague vaccine
33http://hl7.org/fhir/sid/cvxpneumococcal polysaccharide vaccine, 23 valent
100http://hl7.org/fhir/sid/cvxpneumococcal conjugate vaccine, 7 valent
109http://hl7.org/fhir/sid/cvxpneumococcal vaccine, unspecified formulation
70http://hl7.org/fhir/sid/cvxQ fever vaccine
18http://hl7.org/fhir/sid/cvxrabies vaccine, for intramuscular injection RETIRED CODE
40http://hl7.org/fhir/sid/cvxrabies vaccine, for intradermal injection
90http://hl7.org/fhir/sid/cvxrabies vaccine, unspecified formulation
72http://hl7.org/fhir/sid/cvxrheumatic fever vaccine
73http://hl7.org/fhir/sid/cvxRift Valley fever vaccine
34http://hl7.org/fhir/sid/cvxrabies immune globulin
119http://hl7.org/fhir/sid/cvxrotavirus, live, monovalent vaccine
122http://hl7.org/fhir/sid/cvxrotavirus vaccine, unspecified formulation
116http://hl7.org/fhir/sid/cvxrotavirus, live, pentavalent vaccine
74http://hl7.org/fhir/sid/cvxrotavirus, live, tetravalent vaccine
71http://hl7.org/fhir/sid/cvxrespiratory syncytial virus immune globulin, intravenous
93http://hl7.org/fhir/sid/cvxrespiratory syncytial virus monoclonal antibody (palivizumab), intramuscular
06http://hl7.org/fhir/sid/cvxrubella virus vaccine
38http://hl7.org/fhir/sid/cvxrubella and mumps virus vaccine
76http://hl7.org/fhir/sid/cvxStaphylococcus bacteriophage lysate
113http://hl7.org/fhir/sid/cvxtetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (5 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid)
09http://hl7.org/fhir/sid/cvxtetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (2 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid)
115http://hl7.org/fhir/sid/cvxtetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbed
35http://hl7.org/fhir/sid/cvxtetanus toxoid, adsorbed
112http://hl7.org/fhir/sid/cvxtetanus toxoid, unspecified formulation
77http://hl7.org/fhir/sid/cvxtick-borne encephalitis vaccine
13http://hl7.org/fhir/sid/cvxtetanus immune globulin
95http://hl7.org/fhir/sid/cvxtuberculin skin test; old tuberculin, multipuncture device
96http://hl7.org/fhir/sid/cvxtuberculin skin test; purified protein derivative solution, intradermal
97http://hl7.org/fhir/sid/cvxtuberculin skin test; purified protein derivative, multipuncture device
98http://hl7.org/fhir/sid/cvxtuberculin skin test; unspecified formulation
78http://hl7.org/fhir/sid/cvxtularemia vaccine
91http://hl7.org/fhir/sid/cvxtyphoid vaccine, unspecified formulation
25http://hl7.org/fhir/sid/cvxtyphoid vaccine, live, oral
41http://hl7.org/fhir/sid/cvxtyphoid vaccine, parenteral, other than acetone-killed, dried
53http://hl7.org/fhir/sid/cvxtyphoid vaccine, parenteral, acetone-killed, dried (U.S. military)
101http://hl7.org/fhir/sid/cvxtyphoid Vi capsular polysaccharide vaccine
75http://hl7.org/fhir/sid/cvxvaccinia (smallpox) vaccine
105http://hl7.org/fhir/sid/cvxvaccinia (smallpox) vaccine, diluted
79http://hl7.org/fhir/sid/cvxvaccinia immune globulin
21http://hl7.org/fhir/sid/cvxvaricella virus vaccine
81http://hl7.org/fhir/sid/cvxVenezuelan equine encephalitis, inactivated
80http://hl7.org/fhir/sid/cvxVenezuelan equine encephalitis, live, attenuated
92http://hl7.org/fhir/sid/cvxVenezuelan equine encephalitis vaccine, unspecified formulation
36http://hl7.org/fhir/sid/cvxvaricella zoster immune globulin
117http://hl7.org/fhir/sid/cvxvaricella zoster immune globulin (Investigational New Drug)
37http://hl7.org/fhir/sid/cvxyellow fever vaccine
121http://hl7.org/fhir/sid/cvxzoster vaccine, live
998http://hl7.org/fhir/sid/cvxno vaccine administered
999http://hl7.org/fhir/sid/cvxunknown vaccine or immune globulin
99http://hl7.org/fhir/sid/cvxRESERVED - do not use
133http://hl7.org/fhir/sid/cvxpneumococcal conjugate vaccine, 13 valent
134http://hl7.org/fhir/sid/cvxJapanese Encephalitis vaccine for intramuscular administration
137http://hl7.org/fhir/sid/cvxHPV, unspecified formulation
136http://hl7.org/fhir/sid/cvxmeningococcal oligosaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4O)
135http://hl7.org/fhir/sid/cvxinfluenza, high dose seasonal, preservative-free
131http://hl7.org/fhir/sid/cvxHistorical record of a typhus vaccination
132http://hl7.org/fhir/sid/cvxHistorical diphtheria and tetanus toxoids and acellular pertussis, poliovirus, Haemophilus b conjugate and hepatitis B (recombinant) vaccine.
128http://hl7.org/fhir/sid/cvxNovel influenza-H1N1-09, all formulations
125http://hl7.org/fhir/sid/cvxNovel Influenza-H1N1-09, live virus for nasal administration
126http://hl7.org/fhir/sid/cvxNovel influenza-H1N1-09, preservative-free, injectable
127http://hl7.org/fhir/sid/cvxNovel influenza-H1N1-09, injectable
138http://hl7.org/fhir/sid/cvxtetanus and diphtheria toxoids, not adsorbed, for adult use
139http://hl7.org/fhir/sid/cvxTd(adult) unspecified formulation
140http://hl7.org/fhir/sid/cvxInfluenza, seasonal, injectable, preservative free
129http://hl7.org/fhir/sid/cvxJapanese Encephalitis vaccine, unspecified formulation
141http://hl7.org/fhir/sid/cvxInfluenza, seasonal, injectable
142http://hl7.org/fhir/sid/cvxtetanus toxoid, not adsorbed
143http://hl7.org/fhir/sid/cvxAdenovirus, type 4 and type 7, live, oral
144http://hl7.org/fhir/sid/cvxseasonal influenza, intradermal, preservative free
145http://hl7.org/fhir/sid/cvxrespiratory syncytial virus monoclonal antibody (motavizumab), intramuscular
146http://hl7.org/fhir/sid/cvxDiphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate (Meningococcal Protein Conjugate), and Hepatitis B (Recombinant) Vaccine.
147http://hl7.org/fhir/sid/cvxMeningococcal, MCV4, unspecified conjugate formulation(groups A, C, Y and W-135)
148http://hl7.org/fhir/sid/cvxMeningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine
149http://hl7.org/fhir/sid/cvxinfluenza, live, intranasal, quadrivalent
150http://hl7.org/fhir/sid/cvxInfluenza, injectable, quadrivalent, preservative free
151http://hl7.org/fhir/sid/cvxinfluenza nasal, unspecified formulation
152http://hl7.org/fhir/sid/cvxPneumococcal Conjugate, unspecified formulation
153http://hl7.org/fhir/sid/cvxInfluenza, injectable, Madin Darby Canine Kidney, preservative free
154http://hl7.org/fhir/sid/cvxHepatitis A immune globulin
155http://hl7.org/fhir/sid/cvxSeasonal, trivalent, recombinant, injectable influenza vaccine, preservative free
156http://hl7.org/fhir/sid/cvxRho(D) Immune globulin- IV or IM
157http://hl7.org/fhir/sid/cvxRho(D) Immune globulin - IM
158http://hl7.org/fhir/sid/cvxinfluenza, injectable, quadrivalent, contains preservative
159http://hl7.org/fhir/sid/cvxRho(D) Unspecified formulation
160http://hl7.org/fhir/sid/cvxInfluenza A monovalent (H5N1), adjuvanted, National stockpile 2013
801http://hl7.org/fhir/sid/cvxAS03 Adjuvant
161http://hl7.org/fhir/sid/cvxInfluenza, injectable,quadrivalent, preservative free, pediatric
162http://hl7.org/fhir/sid/cvxmeningococcal B vaccine, fully recombinant
163http://hl7.org/fhir/sid/cvxmeningococcal B vaccine, recombinant, OMV, adjuvanted
164http://hl7.org/fhir/sid/cvxmeningococcal B, unspecified formulation
165http://hl7.org/fhir/sid/cvxHuman Papillomavirus 9-valent vaccine
166http://hl7.org/fhir/sid/cvxinfluenza, intradermal, quadrivalent, preservative free, injectable
167http://hl7.org/fhir/sid/cvxmeningococcal vaccine of unknown formulation and unknown serogroups
168http://hl7.org/fhir/sid/cvxSeasonal trivalent influenza vaccine, adjuvanted, preservative free
169http://hl7.org/fhir/sid/cvxHep A, live attenuated-IM
170http://hl7.org/fhir/sid/cvxnon-US diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV)
171http://hl7.org/fhir/sid/cvxInfluenza, injectable, Madin Darby Canine Kidney, preservative free, quadrivalent
172http://hl7.org/fhir/sid/cvxcholera, WC-rBS
173http://hl7.org/fhir/sid/cvxcholera, BivWC
174http://hl7.org/fhir/sid/cvxcholera, live attenuated
175http://hl7.org/fhir/sid/cvxHuman Rabies vaccine from human diploid cell culture
176http://hl7.org/fhir/sid/cvxHuman rabies vaccine from Chicken fibroblast culture
177http://hl7.org/fhir/sid/cvxpneumococcal conjugate vaccine, 10 valent
178http://hl7.org/fhir/sid/cvxNon-US bivalent oral polio vaccine (types 1 and 3)
179http://hl7.org/fhir/sid/cvxNon-US monovalent oral polio vaccine, unspecified formulation
180http://hl7.org/fhir/sid/cvxtetanus immune globulin
181http://hl7.org/fhir/sid/cvxanthrax immune globulin
182http://hl7.org/fhir/sid/cvxOral Polio Vaccine, Unspecified formulation
183http://hl7.org/fhir/sid/cvxYellow fever vaccine alternative formulation
184http://hl7.org/fhir/sid/cvxYellow fever vaccine, unspecified formulation
185http://hl7.org/fhir/sid/cvxSeasonal, quadrivalent, recombinant, injectable influenza vaccine, preservative free
186http://hl7.org/fhir/sid/cvxInfluenza, injectable, Madin Darby Canine Kidney, quadrivalent with preservative
187http://hl7.org/fhir/sid/cvxzoster vaccine recombinant
188http://hl7.org/fhir/sid/cvxzoster vaccine, unspecified formulation
189http://hl7.org/fhir/sid/cvxHepatitis B vaccine (recombinant), CpG adjuvanted
190http://hl7.org/fhir/sid/cvxTyphoid conjugate vaccine (non-US)
191http://hl7.org/fhir/sid/cvxmeningococcal A polysaccharide vaccine (non-US)
192http://hl7.org/fhir/sid/cvxmeningococcal AC polysaccharide vaccine (non-US)
193http://hl7.org/fhir/sid/cvxhepatitis A and hepatitis B vaccine, pediatric/adolescent (non-US)
194http://hl7.org/fhir/sid/cvxinfluenza, Southern Hemisphere, unspecified formulation
195http://hl7.org/fhir/sid/cvxDiphtheria, Tetanus, Poliomyelitis adsorbed
196http://hl7.org/fhir/sid/cvxtetanus and diphtheria toxoids, adsorbed, preservative free, for adult use, Lf unspecified
197http://hl7.org/fhir/sid/cvxinfluenza, high-dose seasonal, quadrivalent, .7mL dose, preservative free
200http://hl7.org/fhir/sid/cvxinfluenza, seasonal, Southern Hemisphere, quadrivalent, pediatric 0.25mL dose, preservative free
201http://hl7.org/fhir/sid/cvxinfluenza, seasonal, Southern Hemisphere, quadrivalent, 0.5mL dose, no preservative
202http://hl7.org/fhir/sid/cvxinfluenza, seasonal, Southern Hemisphere, quadrivalent, 0.5mL dose, with preservative
198http://hl7.org/fhir/sid/cvxDiphtheria, pertussis, tetanus, hepatitis B, Haemophilus Influenza Type b, (Pentavalent)
203http://hl7.org/fhir/sid/cvxmeningococcal polysaccharide (groups A, C, Y, W-135) tetanus toxoid conjugate vaccine .5mL dose, preservative free
205http://hl7.org/fhir/sid/cvxinfluenza, seasonal vaccine, quadrivalent, adjuvanted, .5mL dose, preservative free
206http://hl7.org/fhir/sid/cvxsmallpox monkeypox vaccine, live attenuated, preservative free (National Stockpile)
207http://hl7.org/fhir/sid/cvxSARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 100 mcg/0.5mL dose
208http://hl7.org/fhir/sid/cvxSARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose
213http://hl7.org/fhir/sid/cvxSARS-COV-2 (COVID-19) vaccine, UNSPECIFIED
210http://hl7.org/fhir/sid/cvxSARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-ChAdOx1, preservative free, 0.5 mL
212http://hl7.org/fhir/sid/cvxSARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-Ad26, preservative free, 0.5 ml
204http://hl7.org/fhir/sid/cvxEbola Zaire vaccine, live, recombinant, 1mL dose
214http://hl7.org/fhir/sid/cvxEbola, unspecified
211http://hl7.org/fhir/sid/cvxSARS-COV-2 (COVID-19) vaccine, Subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 0.5mL per dose
AGRPALurn:oid:1.2.36.1.2001.1005.17Agrippal
AVAXMurn:oid:1.2.36.1.2001.1005.17Avaxim
BCGurn:oid:1.2.36.1.2001.1005.17BCG
CDTurn:oid:1.2.36.1.2001.1005.17CDT
CMXurn:oid:1.2.36.1.2001.1005.17COMVAX
DTPurn:oid:1.2.36.1.2001.1005.17Triple Antigen
DTPAurn:oid:1.2.36.1.2001.1005.17DTPa
ENGPurn:oid:1.2.36.1.2001.1005.17Engerix B
FLRIXurn:oid:1.2.36.1.2001.1005.17Fluarix
FLUVAXurn:oid:1.2.36.1.2001.1005.17Fluvax
FLVRNurn:oid:1.2.36.1.2001.1005.17Fluvirin
FVXJNRurn:oid:1.2.36.1.2001.1005.17Fluvax Junior
GNDIPurn:oid:1.2.36.1.2001.1005.17Diphtheria
GNFLUurn:oid:1.2.36.1.2001.1005.17Influenza
GNHEPurn:oid:1.2.36.1.2001.1005.17Hepatitis B
GNHIBurn:oid:1.2.36.1.2001.1005.17HIB
GNHPAurn:oid:1.2.36.1.2001.1005.17Hepatitis A
GNJENurn:oid:1.2.36.1.2001.1005.17Japanese Encephalitis
GNMEAurn:oid:1.2.36.1.2001.1005.17Measles
GNMENurn:oid:1.2.36.1.2001.1005.17Meningococcal C
GNMUMurn:oid:1.2.36.1.2001.1005.17Mumps
GNPNEurn:oid:1.2.36.1.2001.1005.17Pneumococcal
GNPOLurn:oid:1.2.36.1.2001.1005.17Polio
GNROXurn:oid:1.2.36.1.2001.1005.17Rotavirus
GNRUBurn:oid:1.2.36.1.2001.1005.17Rubella
GNTETurn:oid:1.2.36.1.2001.1005.17Tetanus
GNVARurn:oid:1.2.36.1.2001.1005.17Varicella
HATWNJurn:oid:1.2.36.1.2001.1005.17Twinrix Junior
HAVAQurn:oid:1.2.36.1.2001.1005.17Vaqta Paed/Adol
HAVJurn:oid:1.2.36.1.2001.1005.17Havrix Junior
HBOCurn:oid:1.2.36.1.2001.1005.17HibTITER
HBVurn:oid:1.2.36.1.2001.1005.17HBV
HBVPurn:oid:1.2.36.1.2001.1005.17HBVAX II
HBXurn:oid:1.2.36.1.2001.1005.17Hiberix
IFHXurn:oid:1.2.36.1.2001.1005.17Infanrix Hexa
IFIPurn:oid:1.2.36.1.2001.1005.17Infanrix-IPV
IFPAurn:oid:1.2.36.1.2001.1005.17Infanrix Penta
IFXurn:oid:1.2.36.1.2001.1005.17Infanrix
IFXBurn:oid:1.2.36.1.2001.1005.17InfanrixHepB
INFLUVurn:oid:1.2.36.1.2001.1005.17Influvac
IPVurn:oid:1.2.36.1.2001.1005.17IPOL
JEVAXurn:oid:1.2.36.1.2001.1005.17JE-VAX
MENJUGurn:oid:1.2.36.1.2001.1005.17Menjugate
MENTECurn:oid:1.2.36.1.2001.1005.17Meningitec
MENUMEurn:oid:1.2.36.1.2001.1005.17Menomune
MENVAXurn:oid:1.2.36.1.2001.1005.17Mencevax ACWY
MMRurn:oid:1.2.36.1.2001.1005.17MMR
MMRCSLurn:oid:1.2.36.1.2001.1005.17MMR II
MMRSKBurn:oid:1.2.36.1.2001.1005.17Priorix
MNTRXurn:oid:1.2.36.1.2001.1005.17Menitorix
NEISVCurn:oid:1.2.36.1.2001.1005.17NeisVac-C
OPVurn:oid:1.2.36.1.2001.1005.17Polio
Purn:oid:1.2.36.1.2001.1005.17Pertussis
PANVAXurn:oid:1.2.36.1.2001.1005.17Panvax
PDCLurn:oid:1.2.36.1.2001.1005.17Pediacel
PLCLurn:oid:1.2.36.1.2001.1005.17Poliacel
PNEUMOurn:oid:1.2.36.1.2001.1005.17Pneumovax
PRPDurn:oid:1.2.36.1.2001.1005.17ProHIBit
PROQADurn:oid:1.2.36.1.2001.1005.17ProQuad
PRPOMPurn:oid:1.2.36.1.2001.1005.17PedvaxHIB
PRPTurn:oid:1.2.36.1.2001.1005.17ActHIB
PRVNRurn:oid:1.2.36.1.2001.1005.17Prevenar 7
PRVTHurn:oid:1.2.36.1.2001.1005.17Prevenar 13
PRXTEXurn:oid:1.2.36.1.2001.1005.17Priorix-Tetra
QDCLurn:oid:1.2.36.1.2001.1005.17Quadracel
ROTRIXurn:oid:1.2.36.1.2001.1005.17Rotarix
ROTTEQurn:oid:1.2.36.1.2001.1005.17Rotateq
SYNFLXurn:oid:1.2.36.1.2001.1005.17Synflorix
TCLurn:oid:1.2.36.1.2001.1005.17Tripacel
VAXGRPurn:oid:1.2.36.1.2001.1005.17Vaxigrip
VGRJNRurn:oid:1.2.36.1.2001.1005.17Vaxigrip Junior
VLRIXurn:oid:1.2.36.1.2001.1005.17Varilrix
VRVAXurn:oid:1.2.36.1.2001.1005.17Varivax

Additional Language Displays

CodeEnglish (English, en)
54adenovirus, type 4
55adenovirus, type 7
82adenovirus, unspecified formulation
24anthrax
19BCG
27
26cholera, unspecified formulation
29CMVIG
56dengue fever
12
28DT (pediatric)
20DTaP
106DTaP, 5 pertussis antigens
107DTaP, unspecified formulation
110DTaP-Hep B-IPV
50DTaP-Hib
120DTaP-Hib-IPV
130DTaP-IPV
01DTP
22DTP-Hib
102DTP-Hib-Hep B
57hantavirus
52Hep A, adult
83Hep A, ped/adol, 2 dose
84Hep A, ped/adol, 3 dose
31Hep A, pediatric, unspecified formulation
85Hep A, unspecified formulation
104Hep A-Hep B
30HBIG
08Hep B, adolescent or pediatric
42Hep B, adolescent/high risk infant
43Hep B, adult
44Hep B, dialysis
45Hep B, unspecified formulation
58Hep C
59Hep E
60herpes simplex 2
46Hib (PRP-D)
47Hib (HbOC)
48Hib (PRP-T)
49Hib (PRP-OMP)
17Hib, unspecified formulation
51Hib-Hep B
61HIV
118HPV, bivalent
62HPV, quadrivalent
86IG
87IGIV
14IG, unspecified formulation
111influenza, live, intranasal
15influenza, split (incl. purified surface antigen)
16influenza, whole
88influenza, unspecified formulation
123influenza, H5N1-1203
10IPV
02OPV
89polio, unspecified formulation
39Japanese encephalitis SC
63Junin virus
64leishmaniasis
65leprosy
66Lyme disease
03MMR
04M/R
94MMRV
67malaria
05measles
68melanoma
32meningococcal MPSV4
103meningococcal C conjugate
114meningococcal MCV4P
108meningococcal ACWY, unspecified formulation
07mumps
69parainfluenza-3
11pertussis
23plague
33pneumococcal polysaccharide PPV23
100pneumococcal conjugate PCV 7
109pneumococcal, unspecified formulation
70Q fever
18rabies, intramuscular injection
40rabies, intradermal injection
90rabies, unspecified formulation
72rheumatic fever
73Rift Valley fever
34RIG
119rotavirus, monovalent
122rotavirus, unspecified formulation
116rotavirus, pentavalent
74rotavirus, tetravalent
71RSV-IGIV
93RSV-MAb
06rubella
38rubella/mumps
76Staphylococcus bacterio lysate
113Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbed
09Td (adult), 2 Lf tetanus toxoid, preservative free, adsorbed
115Tdap
35
112
77tick-borne encephalitis
13TIG
95TST-OT tine test
96TST-PPD intradermal
97TST-PPD tine test
98TST, unspecified formulation
78
91typhoid, unspecified formulation
25typhoid, oral
41typhoid, parenteral
53typhoid, parenteral, AKD (U.S. military)
101typhoid, ViCPs
75vaccinia (smallpox)
105vaccinia (smallpox) diluted
79
21varicella
81VEE, inactivated
80VEE, live
92VEE, unspecified formulation
36VZIG
117VZIG (IND)
37yellow fever
121zoster live
998
999unknown
99
133Pneumococcal conjugate PCV 13
134Japanese Encephalitis IM
137
136Meningococcal MCV4O
135Influenza, high dose seasonal
131typhus, historical
132DTaP-IPV-HIB-HEP B, historical
128Novel Influenza-H1N1-09, all formulations
125Novel Influenza-H1N1-09, nasal
126Novel influenza-H1N1-09, preservative-free
127Novel influenza-H1N1-09
138Td (adult)
139
140
129Japanese Encephalitis, unspecified formulation
141
142
143Adenovirus types 4 and 7
144influenza, seasonal, intradermal, preservative free
145RSV-MAb (new)
146DTaP,IPV,Hib,HepB
147meningococcal MCV4, unspecified formulation
148Meningococcal C/Y-HIB PRP
149
150influenza, injectable, quadrivalent, preservative free
151
152
153Influenza, injectable, MDCK, preservative free
154Hep A, IG
155influenza, recombinant, injectable, preservative free
156Rho(D)-IG
157Rho(D) -IG IM
158influenza, injectable, quadrivalent
159Rho(D) - Unspecified formulation
160Influenza A monovalent (H5N1), ADJUVANTED-2013
801
161
162meningococcal B, recombinant
163meningococcal B, OMV
164meningococcal B, unspecified
165HPV9
166influenza, intradermal, quadrivalent, preservative free
167meningococcal, unknown serogroups
168influenza, trivalent, adjuvanted
169Hep A, live attenuated
170DTAP/IPV/HIB - non-US
171Influenza, injectable, MDCK, preservative free, quadrivalent
172
173
174
175Rabies - IM Diploid cell culture
176Rabies - IM fibroblast culture
177PCV10
178OPV bivalent
179OPV ,monovalent, unspecified
180
181
182OPV, Unspecified
183Yellow fever vaccine - alt
184Yellow fever, unspecified formulation
185influenza, recombinant, quadrivalent,injectable, preservative free
186Influenza, injectable, MDCK, quadrivalent, preservative
187zoster recombinant
188zoster, unspecified formulation
189HepB-CpG
190Typhoid conjugate vaccine (TCV)
191meningococcal A polysaccharide (non-US)
192meningococcal AC polysaccharide (non-US)
193Hep A-Hep B, pediatric/adolescent
194Influenza, Southern Hemisphere
195DT, IPV adsorbed
196Td, adsorbed, preservative free, adult use, Lf unspecified
197influenza, high-dose, quadrivalent
200influenza, Southern Hemisphere, pediatric, preservative free
201influenza, Southern Hemisphere, preservative free
202influenza, Southern Hemisphere, quadrivalent, with preservative
198DTP-hepB-Hib Pentavalent Non-US
203meningococcal polysaccharide (groups A, C, Y, W-135) TT conjugate
205Influenza vaccine, quadrivalent, adjuvanted
206Smallpox monkeypox vaccine (National Stockpile)
207COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5 mL dose
208COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose
213
210COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL
212COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL
204
214
211COVID-19 vaccine, Subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mL
AGRPAL
AVAXM
BCG
CDT
CMX
DTP
DTPA
ENGP
FLRIX
FLUVAX
FLVRN
FVXJNR
GNDIP
GNFLU
GNHEP
GNHIB
GNHPA
GNJEN
GNMEA
GNMEN
GNMUM
GNPNE
GNPOL
GNROX
GNRUB
GNTET
GNVAR
HATWNJ
HAVAQ
HAVJ
HBOC
HBV
HBVP
HBX
IFHX
IFIP
IFPA
IFX
IFXB
INFLUV
IPV
JEVAX
MENJUG
MENTEC
MENUME
MENVAX
MMR
MMRCSL
MMRSKB
MNTRX
NEISVC
OPV
P
PANVAX
PDCL
PLCL
PNEUMO
PRPD
PROQAD
PRPOMP
PRPT
PRVNR
PRVTH
PRXTEX
QDCL
ROTRIX
ROTTEQ
SYNFLX
TCL
VAXGRP
VGRJNR
VLRIX
VRVAX

 

See the full registry of value sets defined as part of FHIR.


Explanation of the columns that may appear on this page:

LvlA few code lists that FHIR defines are hierarchical - each code is assigned a level. For value sets, levels are mostly used to organize codes for user convenience, but may follow code system hierarchy - see Code System for further information
SourceThe source of the definition of the code (when the value set draws in codes defined elsewhere)
CodeThe code (used as the code in the resource instance). If the code is in italics, this indicates that the code is not selectable ('Abstract')
DisplayThe display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
DefinitionAn explanation of the meaning of the concept
CommentsAdditional notes about how to use the code